![](https://investorshub.advfn.com/uicon/691940.png?cb=1578604518)
Thursday, September 12, 2019 9:01:55 AM
Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction; Public Hearing
SEPTEMBER 17, 2019
FDA White Oak Campus
10903 New Hampshire Avenue
Building 31 Conference Center, Great Room B/C
Silver Spring, MD 20993-0002
https://www.fda.gov/drugs/development-approval-process-drugs/standards-future-opioid-analgesic-approvals-and-incentives-new-therapeutics-treat-pain-and-addiction
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM